|
|
|
|
|
| September 29, 2011 | ISSUE NUMBER 219 VOL 8 |
Partnerships
Prix Galien: Pharma R&D and Payers Need to Talk—Yesterday
R&D departments and payers need to communicate early in the drug development process; if pharma is a day late, then payers are likely to be a dollar short, according to panelists at the Galien Forum on Tuesday ...Read More
R&D
Bringing Genetic Data into the Clinic
While Big Pharma frets over the costs and risks associated with exploratory endpoints in the clinic and the vagaries of companion diagnostic reimbursement, non-profit organizations like the Multiple Myeloma Research Foundation are stepping in to provide pharmacogenomic research for the next generation of cancer drugs ...Read More
Economics
Value Isn’t Just Dollars and Cents
Now that 90 percent of the top 43 countries for drug sales have instituted “significant” cost containment measures, it’s more important than ever to give payers the rest of the story, according to Adam Woodrow, vice president of Pfizer’s specialty care business unit ...Read More
Global Digest
German Pricing, BRUK Economies, and European Guidelines
Pharm Exec Global Digest’s lead feature this month assesses how Germany’s new AMNOG-based pricing system could halt drug launches in the country. There’s also a report on how Ukraine is trying to clean up its patent act, and what the EU is doing to try and break out of its outdated clinical research guidelines
...Read more
Partnerships
The Power of PDP
Can cooperative ties between Big Pharma, NGOs, government, and international organizations pay the freight in making the fight against neglected diseases a permanent fix in global health? ...Read more |
|
|
 // Merck (Whitehouse Station, NJ) announced the appointment of Cuong Viet Do as chief strategy officer, effective Oct. 3. // Jack Bush joined Wolters Kluwer Pharma Solutions (Phoenix, Ariz.) as Vice President, Marketing, for the Healthcare Analytics business. // Catalent Pharma Solutions (Somerset, NJ) appointed Paul Jenkins to the position of Global Vice President, Business Development, Zydis Technology. //
Tatsuo Izumi joined the Board of Directors of MediciNova (San Diego). |
|
|
 |
|
|
|
|
|
|
|
 |
 |
| |
 |
|
 |
| Has your company experienced increased FDA scrutiny during the past year? |
|
|
|
|
You
are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To
ensure delivery to your Inbox, please add us to your
address book. If you need help doing this, click
here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
